Abstract
A designed suicide inhibitor of a postulated, enzyme-catalyzed step in the biosynthesis of the macrotetrolide antibiotic nonactin (1) was synthesized and evaluated in vivo. The inhibitor reduced the rate of nonactin biosynthesis by over 75% while affecting neither biomass production nor the synthesis of other secondary metabolites. The role of the inhibitor in nonactin biosynthesis is discussed.
| Original language | English |
|---|---|
| Pages (from-to) | 2187-2192 |
| Number of pages | 6 |
| Journal | Bioorganic and Medicinal Chemistry Letters |
| Volume | 7 |
| Issue number | 17 |
| DOIs | |
| State | Published - Sep 9 1997 |